Articles related to ANTIDEPRESSANTS
GABAergic Deficit Hypothesis Offers New Framework to Reinvigorate MDD Treatment, Experts Say in Review Article
Explore how a paradigm shift from monoamine to GABAergic systems could offer new, more effective treatments for major depressive disorder; the latest review discusses the unmet needs and the promising potential of NAS GABAA receptor PAMs.
Psychiatry September 6th 2023
Cognitive Biotype, New Depression Subtype, Resistant to Common Antidepressants
Discover the implications of a newly identified depression subtype, “cognitive biotype,” which not only presents with significant cognitive impairments but also shows resistance to standard antidepressant treatments.
Neurology August 30th 2023
Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression
A recent study on bipolar I depression patients found that extended antidepressant maintenance for 52 weeks did not significantly prevent mood episode relapses compared to an 8-week regimen.
Psychiatry August 8th 2023
Ketamine Treatment in TRD Should Last 4 Weeks or More for Antidepressant Benefit
The study on the use of subcutaneous racemic ketamine in treatment-resistant depression underscores the significance of a flexible, individualized dosing approach over a 4-week course.
Psychiatry August 2nd 2023
Study Tackles the Mystery of Brain Zaps in Antidepressant Withdrawal
Explore the results of this study, which shed light on the underreported and frequently misunderstood phenomena of “brain zaps” during antidepressant withdrawal and its effects on medicine use and quality of life.
Psychiatry June 28th 2023